HomeCTX • TSE
add
Crescita Therapeutics Inc
Previous close
$0.62
Day range
$0.56 - $0.62
Year range
$0.36 - $0.69
Market cap
11.29M CAD
Avg Volume
23.76K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 3.59M | 18.50% |
Operating expense | 3.14M | 8.99% |
Net income | -1.04M | 19.19% |
Net profit margin | -28.83 | 31.80% |
Earnings per share | — | — |
EBITDA | -860.00K | 14.34% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 8.44M | -15.80% |
Total assets | 22.68M | -10.59% |
Total liabilities | 6.62M | 5.85% |
Total equity | 16.06M | — |
Shares outstanding | 19.12M | — |
Price to book | 0.74 | — |
Return on assets | -12.84% | — |
Return on capital | -16.64% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -1.04M | 19.19% |
Cash from operations | 424.00K | 239.20% |
Cash from investing | -754.00K | -2,592.86% |
Cash from financing | -227.00K | 29.94% |
Net change in cash | -574.00K | -180.00% |
Free cash flow | -25.88K | -105.26% |
About
Founded
2016
Website
Employees
80
